World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
13188
World Ranking
3002
National Ranking
68

Milos Opravil publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Milos Opravil sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 158 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Milos Opravil D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Milos Opravil sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 61 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Milos Opravil is affiliated with the University of Zurich in Switzerland. Their academic profile is characterized by a presence within the institution, indicating involvement in research and teaching activities at this university.

The available data does not provide details on recent papers, co-authors, publication venues, or specific fields of study. Consequently, no information on particular research topics, subfields, or scientific contributions through publications can be outlined.

There are no records of book publications under their name, nor any documented awards that have been granted to them to date.

This profile therefore focuses primarily on their association within the academic environment of the University of Zurich, without additional details on research output or collaborations.

Best Publications

  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

    Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti

  • Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back

  • AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

    Bruno Ledergerber;M. Egger;V. Erard;R. Weber

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

  • Primary pulmonary hypertension in HIV infection.

    Rudolf Speich;Rolf Jenni;Milos Opravil;Marlene Pfab

  • Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

    Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin

  • HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.

    M. Opravil;Marc Pechere;R. Speich;H. I. Joller-Jemelka

  • Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

    Hansjakob Furrer;Matthias Egger;Milos Opravil;Enos Bernasconi

  • Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.

    Olivier Sitbon;Virginie Gressin;Rudolf Speich;Peter S. Macdonald

  • Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study

    K. Boubaker;Markus Flepp;Philippe Sudre;Hansjakob Furrer

  • Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

    Patrizio Lorenzi;Milos Opravil;Bernard Hirschel;Jean-Philippe Chave

  • Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study.

    Hofer M;Joller-Jemelka Hi;Grob Pj;Lüthy R

  • Pulmonary Arterial Hypertension Related to HIV Infection: Improved Hemodynamics and Survival Associated with Antiretroviral Therapy

    Jean-Philippe Zuber;Alexandra Calmy;John M. Evison;Barbara Hasse

  • A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

    Bernard Hirschel;A. Lazzarin;P. Chopard;M. Opravil

  • Updated European recommendations for the clinical use of HIV drug resistance testing

    A. M. Vandamme;A. Sönnerborg;M. Ait-Khaled;J. Albert

  • A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection

    Milos Opravil;Bernard Hirschel;Adriano Lazzarin;Hansjakob Furrer

  • A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection

    Olivier T. Rutschmann;Milos Opravil;Anne Iten;Raffaele Malinverni

  • Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.

    Enos Bernasconi;Karim Boubaker;Cornelia Junghans;Markus Flepp

  • Enteric Infections and Diarrhea in Human Immunodeficiency Virus-Infected Persons Prospective Community-Based Cohort Study

    Rainer Weber;Bruno Ledergerber;Reinhard Zbinden;Martin Altwegg

  • Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l

    Milos Opravil;Bruno Ledergerber;Hansjakob Furrer;Bernard Hirschel

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

Frequent Co-Authors

Rainer Weber
Rainer Weber University of Zurich
Hansjakob Furrer
Hansjakob Furrer University of Bern
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Bruno Ledergerber
Bruno Ledergerber University of Zurich
Manuel Battegay
Manuel Battegay University Hospital of Basel
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Bernard Hirschel
Bernard Hirschel University of Geneva
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Amalio Telenti
Amalio Telenti VIR Biotechnology (United States)
Marek Fischer
Marek Fischer University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to various healthcare and science-related careers. For those interested in swiftly entering the healthcare industry, exploring fast online medical billing and coding certification programs can provide valuable skills and meaningful employment in administrative roles.

If you're aiming for advanced medical roles, numerous medical degrees online that pay well offer flexible options that could complement a microbiology background, enhancing your expertise and job prospects in fields like healthcare management or medical research.

For public health enthusiasts, enrolling in online MPH programs easy to get into can be an accessible way to boost your qualifications and impact community health, often blending well with microbiology studies.

Additionally, if you are passionate about supporting children’s well-being, learning how much does a child life specialist make and the career requirements can help you decide if this rewarding healthcare path aligns with your skills and interests.

Best Scientists Citing Milos Opravil

Trending Scientists

Recently Published Articles